Meloxicam Al

Meloxicam, the active ingredient in Meloxicam Al, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats inflammation and pain associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients, and is commonly prescribed for chronic musculoskeletal conditions.

GNH USA supplies Meloxicam Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal conditions.

- Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates inflammatory pain and swelling in joints. - Ankylosing spondylitis: diminishes spinal stiffness and associated pain. - Acute pain: provides short‑term relief of moderate pain.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Edema: mild peripheral swelling.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening hemorrhage. - Cardiovascular events: increased risk of heart attack or stroke. - Liver enzyme elevation: signs of hepatic injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating meloxicam therapy, clinicians should evaluate patient risk factors and monitor relevant clinical parameters.

- Renal function: assess baseline creatinine and monitor for deterioration. - Hepatic function: check liver enzymes and avoid use in severe hepatic impairment. - Cardiovascular risk: evaluate history of heart disease or stroke before use. - Gastrointestinal safety: consider ulcer prophylaxis in patients with prior GI bleeding. - Hypersensitivity: discontinue if signs of allergic reaction such as rash or bronchospasm appear. - Store at room temperature: keep in the original container, protect from moisture and light.

Meloxicam can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - ACE inhibitors (e.g., enalapril): may reduce renal function. - Lithium: elevated lithium levels and toxicity.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., sertraline): additive bleeding risk. - Methotrexate: increased methotrexate toxicity. - Diuretics (e.g., thiazides): enhanced potassium loss and renal effects.